Page last updated: 2024-09-04

moxifloxacin and Primary Peritonitis

moxifloxacin has been researched along with Primary Peritonitis in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's6 (50.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Adeniyi, ET; Chen, S; Drießen, D; Ioerger, TR; Kalscheuer, R; Kruppa, M; Müller, TJJ; Rehberg, N; Sommer, GA; Tasch, BOA; Wang, L; Wolf, K; Zhu, K1
Brandt, CT; Figueiredo Filho, CA; Maior, GIS; Marquis, VWPB; Mascena, GV; Moura, LCRV; Paz, ARD1
Brandt, CT; Gadelha, DN; Melo, MC; Oliveira, TK1
Alder, J; Arvis, P; De Waele, JJ; Hussain, T; Kruesmann, F; Solomkin, JS; Tellado, JM; Weiss, G1
Dong, J; Johnson, DW; Qu, Z; Tian, X; Wang, H; Xu, R; Yang, Z1
Hampel, B; Lippert, H; Muehlhofer, E; Reimnitz, P; Weiss, G1
Chen, MJ; Hampel, B; Ma, EL; Solomkin, J; Zhao, YP1
Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Lu, CL1
Cheadle, W; Lee, JT; Napolitano, LM; Nichols, RL1
Chen, X; Guo, X; Shi, G; Wang, H; Wang, S; Zhang, X1
Delesen, H; Kubitza, D; Rink, AD; Stass, H; Vestweber, KH1
Eremina, LV; Iakovlev, SV; Nazarov, VV; Ramishvili, VSh1

Reviews

1 review(s) available for moxifloxacin and Primary Peritonitis

ArticleYear
Clinical update on the use of moxifloxacin in the treatment of community-acquired complicated intraabdominal infections.
    Surgical infections, 2010, Volume: 11, Issue:5

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Peritonitis; Quinolines

2010

Trials

6 trial(s) available for moxifloxacin and Primary Peritonitis

ArticleYear
Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.
    Surgical infections, 2014, Volume: 15, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Treatment Outcome

2014
Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 70, Issue:1

    Topics: Administration, Oral; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Peritoneal Dialysis; Peritoneum; Peritonitis; Pilot Projects; Prospective Studies; Vancomycin

2017
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Appendicitis; Aza Compounds; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Quinolines

2009
Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Asia; Aza Compounds; Ceftriaxone; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Peritonitis; Quinolines; Treatment Outcome

2009
Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Ascitic Fluid; Aza Compounds; Biological Availability; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Peritoneum; Peritonitis; Quinolines

2006
[Efficacy of moxifloxacin in the treatment of secondary peritonitis].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:5

    Topics: Adult; Aged; Anti-Infective Agents; APACHE; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Quinolines; Treatment Outcome

2006

Other Studies

5 other study(ies) available for moxifloxacin and Primary Peritonitis

ArticleYear
Nature-Inspired (di)Azine-Bridged Bisindole Alkaloids with Potent Antibacterial
    Journal of medicinal chemistry, 2020, 11-12, Volume: 63, Issue:21

    Topics: Alkaloids; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Indoles; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Pyruvate Kinase; Rabbits

2020
Role of moxifloxacin-dexamethasone in cardiac histomorphometric findings among Wistar rats from infected mothers.
    Acta cirurgica brasileira, 2018, Volume: 33, Issue:9

    Topics: Animals; Animals, Newborn; Dexamethasone; Disease Models, Animal; Female; Fluoroquinolones; Heart; Moxifloxacin; Myocardium; Organogenesis; Peritonitis; Pregnancy; Pregnancy Complications; Prospective Studies; Rats; Rats, Wistar

2018
Severe autogenously fecal peritonitis in Wistar rats with permanent bilateral carotid occlusion. Response to intra peritoneal moxifloxacin combined with dexamethasone.
    Acta cirurgica brasileira, 2014, Volume: 29, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carotid Artery, Common; Dexamethasone; Drug Combinations; Feces; Fluoroquinolones; Models, Animal; Moxifloxacin; Peritonitis; Rats, Wistar; Reproducibility of Results; Time Factors; Tissue Adhesions; Treatment Outcome

2014
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:12

    Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Community-Acquired Infections; Cross Infection; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Peritonitis; Quinolines; Taiwan; Tigecycline

2009
Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
    The Journal of antibiotics, 2012, Volume: 65, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Space; Fluoroquinolones; Intracellular Space; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Peritonitis; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Time Factors

2012